(Q42818117)

7 November 2017

title

Nocturnal reduction in circulating adiponectin concentrations related to hypoxic stress in severe obstructive sleep apnea-hypopnea syndrome (English)

1 reference

7 November 2017

0 references

11

Tohru Funahashi

1 reference

7 November 2017

Yasuhiko Nakagawa

1

1 reference

7 November 2017

Ken Kishida

2

1 reference

7 November 2017

Shinji Kihara

3

1 reference

7 November 2017

Mina Sonoda

4

1 reference

7 November 2017

Ayumu Hirata

5

1 reference

7 November 2017

Atsutaka Yasui

6

1 reference

7 November 2017

Hitoshi Nishizawa

7

1 reference

7 November 2017

Tadashi Nakamura

8

1 reference

7 November 2017

Ryoko Yoshida

9

1 reference

7 November 2017

Iichiro Shimomura

10

1 reference

7 November 2017

publication date

15 January 2008

1 reference

American Journal of Physiology - Endocrinology and Metabolism

7 November 2017

published in

1 reference

7 November 2017

volume

294

1 reference

7 November 2017

issue

4

1 reference

7 November 2017

page(s)

E778-84

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00709.2007

7 November 2017

1 reference

Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00709.2007

Myocardial ischemia during sleep

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00709.2007

Hypoxia dysregulates the production of adiponectin and plasminogen activator inhibitor-1 independent of reactive oxygen species in adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00709.2007

Sleep apnoea and nocturnal angina.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00709.2007

Day-night pattern of sudden death in obstructive sleep apnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00709.2007

Adiponectin in patients with obstructive sleep apnea syndrome: course and physiological relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00709.2007

Effects of peroxisome proliferator-activated receptor ligands, bezafibrate and fenofibrate, on adiponectin level

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00709.2007

Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00709.2007

Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00709.2007

Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00709.2007

Disturbed secretion of mutant adiponectin associated with the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00709.2007

Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00709.2007

Effect of continuous positive airway pressure on soluble CD40 ligand in patients with obstructive sleep apnea syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00709.2007

Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00709.2007

Obstructive sleep apnea and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00709.2007

Treatment of obstructive sleep apnoea leads to improved microvascular endothelial function in the systemic circulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00709.2007

Obstructive sleep apnoea syndrome--an oxidative stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00709.2007

cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00709.2007

Diet-induced insulin resistance in mice lacking adiponectin/ACRP30

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00709.2007

PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00709.2007

Adrenomedullin can protect against pulmonary vascular remodeling induced by hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00709.2007

Adiponectin accelerates reverse cholesterol transport by increasing high density lipoprotein assembly in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00709.2007

Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00709.2007

Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00709.2007

Targeting adiponectin for cardioprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00709.2007

Adiponectin as an anti-inflammatory factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00709.2007

Sleep apnea: epidemiology, pathophysiology, and relation to cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00709.2007

Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00709.2007

Effects of nocturnal oxygen therapy on outcome measures in patients with chronic heart failure and cheyne-stokes respiration

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00709.2007

Obstructive sleep apnea: implications for cardiac and vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00709.2007

Obesity, and not obstructive sleep apnea, is responsible for metabolic abnormalities in a cohort with sleep-disordered breathing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00709.2007

Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00709.2007

Metabolic disturbances in obesity versus sleep apnoea: the importance of visceral obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00709.2007

Dysregulation of the expression and secretion of inflammation-related adipokines by hypoxia in human adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00709.2007

Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00709.2007

Sleep apnea and heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00709.2007

Oxidative stress in obstructive sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00709.2007

Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00709.2007

Serum adiponectin levels in adult male patients with obstructive sleep apnea hypopnea syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00709.2007

10.1152/AJPENDO.00709.2007

21 January 2018

Identifiers

DOI

1 reference

7 November 2017

1 reference